HomeCOLO-B • CPH
add
Coloplast A/S
Previous close
kr 909.20
Day range
kr 912.00 - kr 930.80
Year range
kr 689.20 - kr 977.60
Market cap
191.70B DKK
Avg Volume
130.50K
P/E ratio
-
Dividend yield
-
Primary exchange
CPH
Market news
Financials
Income Statement
Revenue
Net income
| (DKK) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 6.95B | 11.68% |
Operating expense | 2.81B | 16.58% |
Net income | 1.31B | 6.92% |
Net profit margin | 18.90 | -4.26% |
Earnings per share | 0.08 | -98.60% |
EBITDA | 2.05B | 7.83% |
Effective tax rate | 18.03% | — |
Balance Sheet
Total assets
Total liabilities
| (DKK) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 788.00M | -13.50% |
Total assets | 48.07B | -0.18% |
Total liabilities | 30.13B | -2.36% |
Total equity | 17.94B | — |
Shares outstanding | 225.14M | — |
Price to book | 11.41 | — |
Return on assets | 9.45% | — |
Return on capital | 11.19% | — |
Cash Flow
Net change in cash
| (DKK) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 1.31B | 6.92% |
Cash from operations | 2.05B | 8.88% |
Cash from investing | -432.00M | 94.80% |
Cash from financing | -1.70B | -126.29% |
Net change in cash | -99.00M | -276.79% |
Free cash flow | 688.25M | -85.89% |
About
Coloplast A/S is a Danish multinational company that develops, manufactures and markets medical devices and services related to ostomy, urology, continence, and wound care. Wikipedia
Founded
1957
Headquarters
Website
Employees
16,639
